Epidemiological studies of natural sources of radiation and childhood cancer: current challenges and future perspectives.


Journal

Journal of radiological protection : official journal of the Society for Radiological Protection
ISSN: 1361-6498
Titre abrégé: J Radiol Prot
Pays: England
ID NLM: 8809257

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 22 11 2019
medline: 22 4 2021
entrez: 22 11 2019
Statut: ppublish

Résumé

The empirical estimation of cancer risks in children associated with low-dose ionising radiation (<100 mSv) remains a challenge. The main reason is that the required combination of large sample sizes with accurate and comprehensive exposure assessment is difficult to achieve. An international scientific workshop, 'Childhood cancer and background radiation', organised by the Institute of Social and Preventive Medicine of the University of Bern, brought together researchers in this field to evaluate how epidemiological studies of background radiation and childhood cancer can best improve our understanding of the effects of low-dose ionising radiation. This review summarises and evaluates the findings of these studies with regard to their methodological differences, identifies key limitations and challenges, and proposes ways to move forward. Large childhood cancer registries, such as those in Great Britain, France and Germany, now permit the conducting of studies that should have sufficient statistical power to detect the effects predicted by standard risk models. Nevertheless, larger studies or pooled studies will be needed to investigate disease subgroups. The main challenge is to accurately assess children's individual exposure to radiation from natural sources and from other sources, as well as potentially confounding non-radiation exposures, in such large study populations. For this, the study groups should learn from each other to improve exposure estimation and develop new ways to validate exposure models with personal dosimetry.

Identifiants

pubmed: 31751953
doi: 10.1088/1361-6498/ab5a38
pmc: PMC10654695
mid: NIHMS1942244
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

R1-R23

Subventions

Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States

Références

Health Phys. 2006 Jun;90(6):569-79
pubmed: 16691105
Environ Health Perspect. 2019 Apr;127(4):46002
pubmed: 31017485
J Environ Radioact. 2016 Nov;164:84-90
pubmed: 27442258
Lancet Haematol. 2018 Aug;5(8):e346-e358
pubmed: 30026010
Cancer Discov. 2015 Dec;5(12):1328-43
pubmed: 26408659
Radiat Environ Biophys. 2013 May;52(2):195-209
pubmed: 23529777
J Radiol Prot. 2012 Sep;32(3):205-22
pubmed: 22810503
Stat Med. 1995 Nov 15-30;14(21-22):2487-501
pubmed: 8711283
Radiat Res. 2003 Oct;160(4):408-17
pubmed: 12968933
Int J Cancer. 2011 Apr 1;128(7):1632-43
pubmed: 21280034
J Environ Radioact. 2015 Jan;139:140-148
pubmed: 25464050
J Environ Radioact. 2016 Nov;164:300-311
pubmed: 27544074
Health Phys. 2001 Sep;81(3):272-88
pubmed: 11513461
Radiat Environ Biophys. 2017 May;56(2):127-138
pubmed: 28337585
Leukemia. 2013 Jan;27(1):3-9
pubmed: 22766784
J Radiol Prot. 2016 Mar;36(1):49-66
pubmed: 26613195
Br J Cancer. 2002 Jun 5;86(11):1721-6
pubmed: 12087456
Nat Rev Cancer. 2018 Aug;18(8):471-484
pubmed: 29784935
BMJ. 1994 Jul 16;309(6948):151-4
pubmed: 8044092
J Radiol Prot. 2015 Dec;35(4):835-68
pubmed: 26512630
Environ Health Perspect. 2015 Jun;123(6):622-8
pubmed: 25707026
Eur J Cancer Prev. 2010 May;19(3):173-81
pubmed: 20361423
J Radiol Prot. 2009 Dec;29(4):467-82
pubmed: 19923647
Radiat Environ Biophys. 2016 Mar;55(1):103-24
pubmed: 26880257
Scand J Public Health. 2011 Jul;39(7 Suppl):42-5
pubmed: 21775350
J Radiol Prot. 2017 Jun 26;37(2):459-491
pubmed: 28586320
Health Phys. 2009 Oct;97(4):343-7
pubmed: 19741363
J Radiol Prot. 2006 Sep;26(3):257-76
pubmed: 16926469
Br J Cancer. 2015 Jan 6;112(1):185-93
pubmed: 25314057
Int J Cancer. 2016 Nov 1;139(9):1975-82
pubmed: 27405274
Br J Cancer. 2011 Nov 22;105(11):1783-7
pubmed: 22027710
J Environ Radioact. 2018 Feb;182:174-176
pubmed: 29203328
J Radiol Prot. 2009 Jun;29(2):123-38
pubmed: 19454799
Radiat Prot Dosimetry. 2007;123(1):83-94
pubmed: 16868014
Radiat Environ Biophys. 2011 Mar;50(1):21-35
pubmed: 20931336
Br J Cancer. 2016 Feb 16;114(4):388-94
pubmed: 26882064
Radiat Res. 2010 Sep;174(3):387-402
pubmed: 20726729
Radiat Res. 2009 Sep;172(3):368-82
pubmed: 19708786
Chem Biol Interact. 2012 Apr 5;196(3):59-67
pubmed: 22326931
Radiat Res. 1974 Nov;60(2):302-6
pubmed: 10881712
J Natl Cancer Inst. 2019 Mar 1;111(3):256-263
pubmed: 30020493
Br J Cancer. 2012 Sep 25;107(7):1163-8
pubmed: 22955857
Am J Epidemiol. 2015 Apr 15;181(8):549-62
pubmed: 25731888
Lancet. 2012 Aug 4;380(9840):499-505
pubmed: 22681860
Int J Cancer. 2009 Jun 1;124(11):2658-70
pubmed: 19173295
Environ Health Perspect. 2017 Apr;125(4):714-720
pubmed: 27483500
Radiat Environ Biophys. 2018 Nov;57(4):321-347
pubmed: 30132159
Eur J Cancer. 2017 May;77:31-39
pubmed: 28350996
Environ Res. 2018 Oct;166:466-472
pubmed: 29945121
Int J Hyg Environ Health. 2019 Jan;222(1):49-67
pubmed: 30268646
Epidemiology. 2008 Jul;19(4):536-43
pubmed: 18552587
J Environ Radioact. 2002;62(3):277-86
pubmed: 12164632
Environ Health Perspect. 2013 Oct;121(10):1239-44
pubmed: 23942326
Radiat Prot Dosimetry. 2008;132(2):246-54
pubmed: 18927134
Radiat Prot Dosimetry. 2008;132(2):175-81
pubmed: 19010936
Int J Epidemiol. 1990 Sep;19(3):546-52
pubmed: 2262246
Epidemiology. 2002 Mar;13(2):146-50
pubmed: 11880754
Paediatr Perinat Epidemiol. 2016 Nov;30(6):612-622
pubmed: 27555468
Br J Cancer. 2002 Jun 5;86(11):1727-31
pubmed: 12087457
J Toxicol Environ Health B Crit Rev. 2012;15(5):332-47
pubmed: 22852813

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH